This course will be offered via online livestreaming due to COVID-19 pandemic spread.
This will be 6-day comprehensive review of current standards and practices in the management of patients with blood disorders and malignancy. The course is designed to effectively prepare participants for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology. Advances in clinical pharmacology, molecular genetics and risk assessment, and radiation oncology will be included.
Solid Tumor and Malignant Hematology - September 14-18
Malignant and Benign Hematology - September 17-19
53.5 AMA PRA Category 1 Credits™
53.5 ABIM MOC points
September 14-19, 2020
Houston, Texas 77230, United States